These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37557922)

  • 41. Underexpression of circulating miR-145-5p and miR-133a-3p are associated with breast cancer and immunohistochemical markers.
    García-Magallanes N; Beltran-Ontiveros SA; Leal-León EA; Luque-Ortega F; Romero-Quintana JG; Osuna-Ramirez I; Barbosa-Jasso M; Arámbula-Meraz E
    J Cancer Res Ther; 2020; 16(6):1223-1228. PubMed ID: 33342777
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Downregulation of LncRNA GAS5 causes trastuzumab resistance in breast cancer.
    Li W; Zhai L; Wang H; Liu C; Zhang J; Chen W; Wei Q
    Oncotarget; 2016 May; 7(19):27778-86. PubMed ID: 27034004
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
    Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
    Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of miRNA Signature in Breast Cancer to Predict Neoadjuvant Chemotherapy Response.
    Xing AY; Wang B; Li YH; Chen X; Wang YW; Liu HT; Gao P
    Pathol Oncol Res; 2021; 27():1609753. PubMed ID: 34257614
    [No Abstract]   [Full Text] [Related]  

  • 45. MicroRNA profiling implies new markers of chemoresistance of triple-negative breast cancer.
    Ouyang M; Li Y; Ye S; Ma J; Lu L; Lv W; Chang G; Li X; Li Q; Wang S; Wang W
    PLoS One; 2014; 9(5):e96228. PubMed ID: 24788655
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression pattern of microRNAs related with response to trastuzumab in breast cancer.
    Yang F; Fu Z; Yang M; Sun C; Li Y; Chu J; Zhang Y; Li W; Huang X; Li J; Wu H; Ding X; Yin Y
    J Cell Physiol; 2019 Sep; 234(9):16102-16113. PubMed ID: 30770556
    [TBL] [Abstract][Full Text] [Related]  

  • 47. miR-770-5p-induced cellular switch to sensitize trastuzumab resistant breast cancer cells targeting HER2/EGFR/IGF1R bidirectional crosstalk.
    Noyan S; Gür Dedeoğlu B
    Turk J Biol; 2024; 48(2):153-162. PubMed ID: 39051060
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modulation of MicroRNA-194 and cell migration by HER2-targeting trastuzumab in breast cancer.
    Le XF; Almeida MI; Mao W; Spizzo R; Rossi S; Nicoloso MS; Zhang S; Wu Y; Calin GA; Bast RC
    PLoS One; 2012; 7(7):e41170. PubMed ID: 22829924
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNA-21 as a predictor and prognostic factor for trastuzumab therapy in human epidermal growth factor receptor 2-positive metastatic breast cancer.
    Badr M; Said H; Louka ML; Elghazaly HA; Gaballah A; Atef Abd El Mageed M
    J Cell Biochem; 2019 Mar; 120(3):3459-3466. PubMed ID: 30246355
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Posttranscriptional upregulation of HER3 by HER2 mRNA induces trastuzumab resistance in breast cancer.
    Li X; Xu Y; Ding Y; Li C; Zhao H; Wang J; Meng S
    Mol Cancer; 2018 Aug; 17(1):113. PubMed ID: 30068375
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exosome-transmitted miR-567 reverses trastuzumab resistance by inhibiting ATG5 in breast cancer.
    Han M; Hu J; Lu P; Cao H; Yu C; Li X; Qian X; Yang X; Yang Y; Han N; Dou D; Zhang F; Ye M; Yang C; Gu Y; Dong H
    Cell Death Dis; 2020 Jan; 11(1):43. PubMed ID: 31969559
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel necroptosis-associated miRNA signature predicting prognosis of endometrial cancer and correlated with immune infiltration.
    Ye Z; Jiang Y; Wu J
    Taiwan J Obstet Gynecol; 2023 Mar; 62(2):291-298. PubMed ID: 36965898
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNA-34c-3p promotes cell proliferation and invasion in hepatocellular carcinoma by regulation of NCKAP1 expression.
    Xiao CZ; Wei W; Guo ZX; Zhang MY; Zhang YF; Wang JH; Shi M; Wang HY; Guo RP
    J Cancer Res Clin Oncol; 2017 Feb; 143(2):263-273. PubMed ID: 27704267
    [TBL] [Abstract][Full Text] [Related]  

  • 54. miR-126 reduces trastuzumab resistance by targeting PIK3R2 and regulating AKT/mTOR pathway in breast cancer cells.
    Fu R; Tong JS
    J Cell Mol Med; 2020 Jul; 24(13):7600-7608. PubMed ID: 32410348
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A two-miRNA signature of upregulated miR-185-5p and miR-362-5p as a blood biomarker for breast cancer.
    Zhang K; Wang YY; Xu Y; Zhang L; Zhu J; Si PC; Wang YW; Ma R
    Pathol Res Pract; 2021 Jun; 222():153458. PubMed ID: 33962174
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Potentiality of a triple microRNA classifier: miR-193a-3p, miR-23a and miR-338-5p for early detection of colorectal cancer.
    Yong FL; Law CW; Wang CW
    BMC Cancer; 2013 Jun; 13():280. PubMed ID: 23758639
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection.
    Matamala N; Vargas MT; González-Cámpora R; Miñambres R; Arias JI; Menéndez P; Andrés-León E; Gómez-López G; Yanowsky K; Calvete-Candenas J; Inglada-Pérez L; Martínez-Delgado B; Benítez J
    Clin Chem; 2015 Aug; 61(8):1098-106. PubMed ID: 26056355
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer.
    Wang K; Chen M; Wu W
    World J Surg Oncol; 2017 Sep; 15(1):175. PubMed ID: 28927412
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of potential microRNA diagnostic panels and uncovering regulatory mechanisms in breast cancer pathogenesis.
    Sharifi Z; Talkhabi M; Taleahmad S
    Sci Rep; 2022 Nov; 12(1):20135. PubMed ID: 36418345
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer.
    Gong C; Yao Y; Wang Y; Liu B; Wu W; Chen J; Su F; Yao H; Song E
    J Biol Chem; 2011 May; 286(21):19127-37. PubMed ID: 21471222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.